Our data show, to our knowledge for the first time, that andrographolide treatment reduced the severity of LPS-induced ALI, more likely by virtue of andrographolide-mediated NF-κB inhibition at the level of IKKβ activation. The gene discussed is IKBKB; the disease is acute respiratory distress syndrome.